Teleflex (TFX) Competitors

Teleflex (NYSE:TFX) and DexCom (NASDAQ:DXCM) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, community ranking, valuation, dividends and media sentiment.

Which has stronger valuation & earnings, TFX or DXCM?

DexCom has higher revenue and earnings than Teleflex. DexCom is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$3.05B	2.01	$356.33M	$1.42	92.97
DexCom	$4.03B	6.55	$576.20M	$1.43	47.13

Does the media refer more to TFX or DXCM?

In the previous week, DexCom had 18 more articles in the media than Teleflex. MarketBeat recorded 44 mentions for DexCom and 26 mentions for Teleflex. DexCom's average media sentiment score of 1.13 beat Teleflex's score of 0.83 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	14 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	23 Very Positive mention(s)	6 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of TFX or DXCM?

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 1.4% of Teleflex shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has more volatility & risk, TFX or DXCM?

Teleflex has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, DexCom has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500.

Does the MarketBeat Community favor TFX or DXCM?

DexCom received 456 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 71.78% of users gave DexCom an outperform vote while only 58.57% of users gave Teleflex an outperform vote.

Company	Underperform	Outperform
Teleflex	Outperform Votes 526 58.57%	Underperform Votes 372 41.43%
DexCom	Outperform Votes 982 71.78%	Underperform Votes 386 28.22%

Do analysts rate TFX or DXCM?

Teleflex presently has a consensus price target of $181.50, indicating a potential upside of 37.48%. DexCom has a consensus price target of $99.00, indicating a potential upside of 46.91%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.09
DexCom	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	3 Strong Buy rating(s)	2.95

Is TFX or DXCM more profitable?

DexCom has a net margin of 14.29% compared to Teleflex's net margin of 7.85%. DexCom's return on equity of 30.14% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	7.85%	14.19%	8.53%
DexCom	14.29%	30.14%	10.11%

Summary

DexCom beats Teleflex on 18 of the 19 factors compared between the two stocks.